Related Experiment Video
Updated: Nov 10, 2025

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
Genomic Epidemiology of Candida auris in Qatar Reveals Hospital Transmission Dynamics and a South Asian Origin
Husam Salah1, Sathyavathi Sundararaju2, Lamya Dalil2
1Division of Microbiology, Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar.
Abstract:
Candida auris is an emerging, multidrug-resistant fungal pathogen that has become a public health threat with an increasing incidence of infections worldwide. Candida auris spreads easily among patients within and between hospitals. Infections and outbreaks caused by C. auris have been reported in the Middle East region including Oman, Kuwait, Saudi Arabia, and Qatar; however, the origin of these isolates is largely unknown. Pathogen whole genome sequencing (WGS) was used to determine the epidemiology and drug resistance mutations of C. auris in Qatar. Forty-four samples isolated from patients in three hospitals and the hospital environment were sequenced by Illumina NextSeq. Core genome single nucleotide polymorphisms (SNPs) revealed that all isolates belonged to the South Asian lineage with genetic heterogeneity that suggests previous acquisition from foreign healthcare. The genetic variability among the outbreak isolates in the two hospitals (A and B) was low. Four environmental isolates clustered with the related clinical isolates, and epidemiologically linked isolates clustered together, suggesting that the ongoing transmission of C. auris could be linked to infected/colonized patients and the hospital environment. Prominent mutations Y132F and K143R in ERG11 linked to increased fluconazole resistance were detected.
Insights
Multidrug-resistant Candida auris is a growing global threat. Whole genome sequencing in Qatar revealed South Asian lineage isolates, suggesting foreign healthcare origins and potential transmission via patients and hospital environments.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Genomics
Background:
- Emerging multidrug-resistant fungal pathogen, *Candida auris*, poses a significant global public health threat.
- Increasing incidence of *C. auris* infections worldwide, with easy transmission in healthcare settings.
- Outbreaks reported in the Middle East, including Qatar, but isolate origins remain largely unknown.
Purpose of the Study:
- To determine the epidemiology and identify drug resistance mutations of *Candida auris* in Qatar using whole genome sequencing (WGS).
Main Methods:
- Whole genome sequencing (WGS) of 44 *C. auris* samples from patients and hospital environments in Qatar using Illumina NextSeq.
- Core genome single nucleotide polymorphism (SNP) analysis.
Main Results:
- All sequenced isolates belonged to the South Asian lineage, indicating potential acquisition from foreign healthcare systems.
- Low genetic variability among outbreak isolates in two hospitals (A and B).
- Environmental isolates clustered with clinical isolates; epidemiologically linked isolates clustered together, suggesting patient and environmental transmission routes.
- Detected mutations Y132F and K143R in *ERG11*, associated with increased fluconazole resistance.
Conclusions:
- The findings suggest *C. auris* in Qatar originated from foreign healthcare sources and is transmitted through patients and the hospital environment.
- Identified specific genetic mutations linked to antifungal resistance, providing insights for treatment and control strategies.
- WGS is effective for tracking *C. auris* transmission dynamics and understanding resistance mechanisms.
More Related Videos
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.

